Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Dragon
alkaloid |
| gptkbp:antidote |
no specific antidote
|
| gptkbp:CASNumber |
60-09-3
|
| gptkbp:chemicalFormula |
C36H51NO11
|
| gptkbp:effect |
causes persistent depolarization of neurons
prevents inactivation of sodium channels |
| gptkbp:firstIsolatedFrom |
1890
|
| gptkbp:foundIn |
gptkb:Schoenocaulon_officinale
plants of the genus Veratrum |
| https://www.w3.org/2000/01/rdf-schema#label |
veratridine
|
| gptkbp:IUPACName |
gptkb:(2β,3β,4β,9β,10β,16β,23ξ)-Veratraman-3,4,9,16,23-pentol_β-D-glucopyranoside
|
| gptkbp:mechanismOfAction |
voltage-gated sodium channel activator
|
| gptkbp:meltingPoint |
220–221 °C
|
| gptkbp:molecularWeight |
677.8 g/mol
|
| gptkbp:namedAfter |
Veratrum (plant genus)
|
| gptkbp:PubChem_CID |
443881
|
| gptkbp:routeOfExposure |
oral
inhalation dermal |
| gptkbp:solubility |
soluble in water and ethanol
|
| gptkbp:toxicity |
toxic to humans and animals
|
| gptkbp:uses |
neuroscience research
|
| gptkbp:bfsParent |
gptkb:Veratrum
|
| gptkbp:bfsLayer |
7
|